A detailed history of Geneos Wealth Management Inc. transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Geneos Wealth Management Inc. holds 1,891 shares of TAK stock, worth $25,036. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,891
Previous 116 1530.17%
Holding current value
$25,036
Previous $1,000 2500.0%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$13.0 - $15.08 $23,075 - $26,767
1,775 Added 1530.17%
1,891 $26,000
Q1 2024

May 03, 2024

SELL
$13.89 - $15.04 $69 - $75
-5 Reduced 4.13%
116 $1,000
Q4 2023

Jan 26, 2024

BUY
$13.36 - $15.43 $146 - $169
11 Added 10.0%
121 $1,000
Q3 2023

Oct 11, 2023

BUY
$15.03 - $16.32 $75 - $81
5 Added 4.76%
110 $1,000
Q1 2023

Apr 25, 2023

BUY
$15.28 - $16.48 $1,604 - $1,730
105 New
105 $1,000
Q2 2022

Jul 22, 2022

SELL
$13.12 - $15.03 $2,807 - $3,216
-214 Reduced 19.12%
905 $12,000
Q4 2021

Feb 09, 2022

SELL
$13.17 - $16.4 $11,787 - $14,677
-895 Reduced 44.44%
1,119 $15,000
Q2 2021

Jul 08, 2021

SELL
$16.55 - $18.64 $1,688 - $1,901
-102 Reduced 4.82%
2,014 $33,000
Q1 2021

Jun 17, 2021

BUY
$16.71 - $19.9 $584 - $696
35 Added 1.68%
2,116 $35,000
Q4 2020

May 19, 2021

SELL
$15.39 - $18.97 $37,443 - $46,154
-2,433 Reduced 53.9%
2,081 $38,000
Q1 2020

Sep 07, 2021

BUY
$13.02 - $20.31 $42,249 - $65,905
3,245 Added 255.71%
4,514 $69,000
Q2 2019

Sep 07, 2021

SELL
$16.58 - $20.49 $1,624 - $2,008
-98 Reduced 7.17%
1,269 $22,000
Q1 2019

Sep 07, 2021

BUY
$16.7 - $21.52 $16,750 - $21,584
1,003 Added 275.55%
1,367 $27,000
Q1 2017

Sep 07, 2021

BUY
N/A
364
364 $8,000

Others Institutions Holding TAK

About TAKEDA PHARMACEUTICAL CO LTD


  • Ticker TAK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 3,109,050,112
  • Market Cap $41.2B
  • Description
  • Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...
More about TAK
Track This Portfolio

Track Geneos Wealth Management Inc. Portfolio

Follow Geneos Wealth Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geneos Wealth Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Geneos Wealth Management Inc. with notifications on news.